Annual revenue:
$675.04M+$192.66M(+39.94%)Summary
- As of today (May 21, 2025), CORT annual revenue is $675.04 million, with the most recent change of +$192.66 million (+39.94%) on December 31, 2024.
- During the last 3 years, CORT annual revenue has risen by +$309.06 million (+84.45%).
- CORT annual revenue is now at all-time high.
Performance
CORT Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
$157.21M-$24.68M(-13.57%)Summary
- As of today (May 21, 2025), CORT quarterly revenue is $157.21 million, with the most recent change of -$24.68 million (-13.57%) on March 31, 2025.
- Over the past year, CORT quarterly revenue has increased by +$10.41 million (+7.09%).
- CORT quarterly revenue is now -13.88% below its all-time high of $182.55 million, reached on September 30, 2024.
Performance
CORT Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
$685.45M+$10.41M(+1.54%)Summary
- As of today (May 21, 2025), CORT TTM revenue is $685.45 million, with the most recent change of +$10.41 million (+1.54%) on March 31, 2025.
- Over the past year, CORT TTM revenue has increased by +$161.92 million (+30.93%).
- CORT TTM revenue is now at all-time high.
Performance
CORT TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
CORT Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +39.9% | +7.1% | +30.9% |
| 3 y3 years | +84.5% | +67.8% | +80.3% |
| 5 y5 years | +120.3% | +68.6% | +104.7% |
CORT Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +84.5% | -13.9% | +67.8% | at high | +80.3% |
| 5 y | 5-year | at high | +120.3% | -13.9% | +97.9% | at high | +104.7% |
| alltime | all time | at high | >+9999.0% | -13.9% | >+9999.0% | at high | >+9999.0% |
CORT Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $157.21M(-13.6%) | $685.45M(+1.5%) |
| Dec 2024 | $675.04M(+39.9%) | $181.89M(-0.4%) | $675.04M(+7.4%) |
| Sep 2024 | - | $182.55M(+11.4%) | $628.55M(+10.3%) |
| Jun 2024 | - | $163.80M(+11.6%) | $569.61M(+8.8%) |
| Mar 2024 | - | $146.81M(+8.4%) | $523.53M(+8.5%) |
| Dec 2023 | $482.38M(+20.0%) | $135.41M(+9.6%) | $482.38M(+7.2%) |
| Sep 2023 | - | $123.60M(+5.0%) | $450.03M(+5.1%) |
| Jun 2023 | - | $117.72M(+11.4%) | $428.15M(+3.5%) |
| Mar 2023 | - | $105.65M(+2.5%) | $413.82M(+3.0%) |
| Dec 2022 | $401.86M(+9.8%) | $103.06M(+1.3%) | $401.86M(+1.1%) |
| Sep 2022 | - | $101.73M(-1.6%) | $397.62M(+1.4%) |
| Jun 2022 | - | $103.39M(+10.4%) | $392.03M(+3.1%) |
| Mar 2022 | - | $93.69M(-5.2%) | $380.23M(+3.9%) |
| Dec 2021 | $365.98M(+3.4%) | $98.82M(+2.8%) | $365.98M(+3.7%) |
| Sep 2021 | - | $96.13M(+5.0%) | $352.89M(+2.9%) |
| Jun 2021 | - | $91.59M(+15.3%) | $343.09M(+0.9%) |
| Mar 2021 | - | $79.44M(-7.3%) | $340.06M(-3.9%) |
| Dec 2020 | $353.87M(+15.5%) | $85.73M(-0.7%) | $353.87M(-0.6%) |
| Sep 2020 | - | $86.33M(-2.5%) | $356.03M(+1.4%) |
| Jun 2020 | - | $88.56M(-5.0%) | $351.21M(+4.9%) |
| Mar 2020 | - | $93.25M(+6.1%) | $334.90M(+9.3%) |
| Dec 2019 | $306.49M(+22.0%) | $87.89M(+7.8%) | $306.49M(+7.4%) |
| Sep 2019 | - | $81.50M(+12.8%) | $285.42M(+6.4%) |
| Jun 2019 | - | $72.26M(+11.5%) | $268.36M(+3.8%) |
| Mar 2019 | - | $64.83M(-3.0%) | $258.42M(+2.9%) |
| Dec 2018 | $251.25M(+57.8%) | $66.83M(+3.7%) | $251.25M(+5.7%) |
| Sep 2018 | - | $64.44M(+3.4%) | $237.70M(+10.0%) |
| Jun 2018 | - | $62.31M(+8.1%) | $216.01M(+14.1%) |
| Mar 2018 | - | $57.66M(+8.2%) | $189.26M(+18.9%) |
| Dec 2017 | $159.20M | $53.28M(+24.6%) | $159.20M(+22.7%) |
| Sep 2017 | - | $42.76M(+20.3%) | $129.73M(+19.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2017 | - | $35.56M(+28.8%) | $108.69M(+17.1%) |
| Mar 2017 | - | $27.60M(+15.9%) | $92.86M(+14.2%) |
| Dec 2016 | $81.32M(+61.7%) | $23.81M(+9.6%) | $81.32M(+12.2%) |
| Sep 2016 | - | $21.73M(+10.1%) | $72.48M(+13.2%) |
| Jun 2016 | - | $19.72M(+22.8%) | $64.01M(+13.8%) |
| Mar 2016 | - | $16.06M(+7.3%) | $56.24M(+11.9%) |
| Dec 2015 | $50.29M(+89.4%) | $14.97M(+12.9%) | $50.29M(+13.4%) |
| Sep 2015 | - | $13.26M(+10.9%) | $44.33M(+15.6%) |
| Jun 2015 | - | $11.96M(+18.4%) | $38.35M(+18.9%) |
| Mar 2015 | - | $10.10M(+12.1%) | $32.25M(+21.5%) |
| Dec 2014 | $26.55M(+156.4%) | $9.01M(+23.8%) | $26.55M(+22.6%) |
| Sep 2014 | - | $7.28M(+24.5%) | $21.65M(+27.3%) |
| Jun 2014 | - | $5.85M(+32.8%) | $17.00M(+30.4%) |
| Mar 2014 | - | $4.41M(+7.0%) | $13.04M(+26.0%) |
| Dec 2013 | $10.36M(+213.2%) | $4.12M(+56.2%) | $10.36M(+35.9%) |
| Sep 2013 | - | $2.63M(+39.3%) | $7.62M(+26.1%) |
| Jun 2013 | - | $1.89M(+10.1%) | $6.04M(+20.2%) |
| Mar 2013 | - | $1.72M(+24.7%) | $5.02M(+51.9%) |
| Dec 2012 | $3.31M(>+9900.0%) | $1.38M(+30.5%) | $3.31M(+71.3%) |
| Sep 2012 | - | $1.05M(+20.6%) | $1.93M(+120.6%) |
| Jun 2012 | - | $875.00K(>+9900.0%) | $875.00K(+266.1%) |
| Dec 2009 | $29.00K(-86.1%) | - | - |
| Jun 2009 | - | $6000.00(-75.0%) | $239.00K(+2.6%) |
| Mar 2009 | - | $24.00K(-83.2%) | $233.00K(+11.5%) |
| Dec 2008 | $209.00K(-56.6%) | $143.00K(+116.7%) | $209.00K(+216.7%) |
| Sep 2008 | - | $66.00K(-82.4%) | $66.00K(-88.1%) |
| Dec 2007 | $482.00K(+63.9%) | - | - |
| Jun 2007 | - | $374.00K(+246.3%) | $555.00K(+97.5%) |
| Mar 2007 | - | $108.00K(+47.9%) | $281.00K(-4.4%) |
| Dec 2006 | $294.00K | $73.00K(-27.0%) | $294.00K(+33.0%) |
| Jun 2006 | - | $100.00K(-17.4%) | $221.00K(+82.6%) |
| Mar 2006 | - | $121.00K | $121.00K |
FAQ
- What is Corcept Therapeutics Incorporated annual revenue?
- What is the all time high annual revenue for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated annual revenue year-on-year change?
- What is Corcept Therapeutics Incorporated quarterly revenue?
- What is the all time high quarterly revenue for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated quarterly revenue year-on-year change?
- What is Corcept Therapeutics Incorporated TTM revenue?
- What is the all time high TTM revenue for Corcept Therapeutics Incorporated?
- What is Corcept Therapeutics Incorporated TTM revenue year-on-year change?
What is Corcept Therapeutics Incorporated annual revenue?
The current annual revenue of CORT is $675.04M
What is the all time high annual revenue for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high annual revenue is $675.04M
What is Corcept Therapeutics Incorporated annual revenue year-on-year change?
Over the past year, CORT annual revenue has changed by +$192.66M (+39.94%)
What is Corcept Therapeutics Incorporated quarterly revenue?
The current quarterly revenue of CORT is $157.21M
What is the all time high quarterly revenue for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high quarterly revenue is $182.55M
What is Corcept Therapeutics Incorporated quarterly revenue year-on-year change?
Over the past year, CORT quarterly revenue has changed by +$10.41M (+7.09%)
What is Corcept Therapeutics Incorporated TTM revenue?
The current TTM revenue of CORT is $685.45M
What is the all time high TTM revenue for Corcept Therapeutics Incorporated?
Corcept Therapeutics Incorporated all-time high TTM revenue is $685.45M
What is Corcept Therapeutics Incorporated TTM revenue year-on-year change?
Over the past year, CORT TTM revenue has changed by +$161.92M (+30.93%)